Skip to content
ABOUT
AUTHOR GUIDELINES
AUTHORS/EDITORS
SUBSCRIPTIONS
CONTACT US
MY ACCOUNT
Facebook
X
LinkedIn
Instagram
Search
×
HOME
PSYCH. BULLETIN
LATEST ISSUE
BLACK BOOK OF DOSING & MONITORING
RATING SCALES
LICENSING INFORMATION
RESOURCES
PSYCHOTROPICS A-Z
PSYCHOPHARMACOLOGY 101
NEWS
Home
Sophie Robert, PharmD – An Open-Label Assessment of Aripiprazole in the Treatment of PTSD
Sophie Robert, PharmD – An Open-Label Assessment of Aripiprazole in the Treatment of PTSD
$
30.00
Sophie Robert, PharmD - An Open-Label Assessment of Aripiprazole in the Treatment of PTSD quantity
Add to cart
Want a discount? Become a member by purchasing
Psychopharmacology Bulletin Subscription - Individual
!
SKU:
pb-42-1-robert
Categories:
Psychopharmacology Bulletin
,
VOL 42 No. 1 Articles
Tags:
aripiprazole
,
helen-g-ulmer
,
mark-b-hamner
,
mary-w-brown
,
medworks-media
,
no-1
,
posttraumatic-stress-disorder
,
psychopharmacology
,
psychopharmacology-bulletin
,
second-generation-antipsychotics
,
sophie-robert
,
treatment
,
valerie-l-durkalski
,
volume-42
Description
Description
Sophie Robert, PharmD
ORIGINAL RESEARCH
An Open-Label Assessment of Aripiprazole in the Treatment of PTSD
Sophie Robert, Mark B. Hamner, Valerie L. Durkalski, Mary W. Brown, Helen G. Ulmer
MWM_PSB-42-01-2009-ROBERT
Related products
Long Acting Risperidone in an Adolescent – Mustafa Deniz Tutkunkardas
$
30.00
Add to cart
Details
Test of Treatment in Psychiatric Practice by Feras Ali Mustafa
$
30.00
Add to cart
Details
Clinical Predictors of Response to Clozapine by Rajkumar A.P.
$
30.00
Add to cart
Details
Trazodone for Depressed Mood, Anxiety, Insomnia, and Suicidality
$
30.00
Add to cart
Details
Page load link
Go to Top